These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 3994895)

  • 1. Genetic polymorphism of mephenytoin p(4')-hydroxylation: difference between Orientals and Caucasians.
    Jurima M; Inaba T; Kadar D; Kalow W
    Br J Clin Pharmacol; 1985 Apr; 19(4):483-7. PubMed ID: 3994895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mephenytoin and sparteine pharmacogenetics in Canadian Caucasians.
    Inaba T; Jurima M; Nakano M; Kalow W
    Clin Pharmacol Ther; 1984 Nov; 36(5):670-6. PubMed ID: 6488688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mephenytoin hydroxylation deficiency in Caucasians: frequency of a new oxidative drug metabolism polymorphism.
    Wedlund PJ; Aslanian WS; McAllister CB; Wilkinson GR; Branch RA
    Clin Pharmacol Ther; 1984 Dec; 36(6):773-80. PubMed ID: 6499356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations.
    Nakamura K; Goto F; Ray WA; McAllister CB; Jacqz E; Wilkinson GR; Branch RA
    Clin Pharmacol Ther; 1985 Oct; 38(4):402-8. PubMed ID: 4042523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mephenytoin hydroxylation in the Cuna Amerindians of Panama.
    Inaba T; Jorge LF; Arias TD
    Br J Clin Pharmacol; 1988 Jan; 25(1):75-9. PubMed ID: 3370193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of S-mephenytoin hydroxylation deficiency in a Korean population and the interphenotypic differences in diazepam pharmacokinetics.
    Sohn DR; Kusaka M; Ishizaki T; Shin SG; Jang IJ; Shin JG; Chiba K
    Clin Pharmacol Ther; 1992 Aug; 52(2):160-9. PubMed ID: 1505151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Family studies of mephenytoin hydroxylation deficiency.
    Inaba T; Jurima M; Kalow W
    Am J Hum Genet; 1986 May; 38(5):768-72. PubMed ID: 3717162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotyping polymorphic drug metabolism in the French Caucasian population.
    Jacqz E; Dulac H; Mathieu H
    Eur J Clin Pharmacol; 1988; 35(2):167-71. PubMed ID: 3191936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metoprolol and mephenytoin oxidation polymorphisms in Far Eastern Oriental subjects: Japanese versus mainland Chinese.
    Horai Y; Nakano M; Ishizaki T; Ishikawa K; Zhou HH; Zhou BI; Liao CL; Zhang LM
    Clin Pharmacol Ther; 1989 Aug; 46(2):198-207. PubMed ID: 2758729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphism of 4'-hydroxylation of S-mephenytoin in 148 Chinese of Han nationality.
    Ruan ZR; Cheng YS; Zhou JF; Zhao Y; Pan YZ; Ding DY
    Zhongguo Yao Li Xue Bao; 1996 Mar; 17(2):119-21. PubMed ID: 9772658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A major pathway of mephenytoin metabolism in man. Aromatic hydroxylation to p-hydroxymephenytoin.
    Küpfer A; Brilis GM; Watson JT; Harris TM
    Drug Metab Dispos; 1980; 8(1):1-4. PubMed ID: 6102023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphism of mephenytoin metabolism.
    Inaba T
    Prog Clin Biol Res; 1986; 214():139-56. PubMed ID: 3523505
    [No Abstract]   [Full Text] [Related]  

  • 13. Mephenytoin hydroxylation polymorphism: characterization of the enzymatic deficiency in liver microsomes of poor metabolizers phenotyped in vivo.
    Meier UT; Dayer P; Malè PJ; Kronbach T; Meyer UA
    Clin Pharmacol Ther; 1985 Nov; 38(5):488-94. PubMed ID: 4053486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S-mephenytoin 4-hydroxylase is inherited as an autosomal-recessive trait in Japanese families.
    Ward SA; Goto F; Nakamura K; Jacqz E; Wilkinson GR; Branch RA
    Clin Pharmacol Ther; 1987 Jul; 42(1):96-9. PubMed ID: 3595072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics of mephenytoin: a new drug hydroxylation polymorphism in man.
    Küpfer A; Preisig R
    Eur J Clin Pharmacol; 1984; 26(6):753-9. PubMed ID: 6489416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereoselective mephobarbital hydroxylation cosegregates with mephenytoin hydroxylation.
    Küpfer A; Branch RA
    Clin Pharmacol Ther; 1985 Oct; 38(4):414-8. PubMed ID: 4042524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism in hydroxylation of mephenytoin and hexobarbital stereoisomers in relation to hepatic P-450 human-2.
    Yasumori T; Murayama N; Yamazoe Y; Kato R
    Clin Pharmacol Ther; 1990 Mar; 47(3):313-22. PubMed ID: 2311333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dapsone N-acetylation, metoprolol alpha-hydroxylation, and S-mephenytoin 4-hydroxylation polymorphisms in an Indonesian population: a cocktail and extended phenotyping assessment trial.
    Setiabudy R; Kusaka M; Chiba K; Darmansjah I; Ishizaki T
    Clin Pharmacol Ther; 1994 Aug; 56(2):142-53. PubMed ID: 8062490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphic debrisoquine and mephenytoin hydroxylation in patients with pulmonary hypertension of vascular origin after aminorex fumarate.
    Saner H; Gurtner HP; Preisig R; Küpfer A
    Eur J Clin Pharmacol; 1986; 31(4):437-42. PubMed ID: 3816924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP2C19 genotyping and associated mephenytoin hydroxylation polymorphism in a Canadian Inuit population.
    Jurima-Romet M; Goldstein JA; LeBelle M; Aubin RA; Foster BC; Walop W; Rode A
    Pharmacogenetics; 1996 Aug; 6(4):329-39. PubMed ID: 8873219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.